Results 231 to 240 of about 183,149 (258)

MMRV vaccine safety

Vaccine, 2019
Patrick, Cashman, Sarah, Moberley, David, Durrheim   +2 more
openaire   +2 more sources

Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems

Vaccine, 2022
Allison Naleway, Michael Jackson, Lina S Sy   +2 more
exaly  

Protecting Vaccine Safety: An Improved, Blockchain-Based, Storage-Efficient Scheme

IEEE Transactions on Cybernetics, 2023
Fei Chen, Jianqiang Li, Laizhong Cui
exaly  

SAFETY OF PERTUSSIS VACCINE

The Lancet, 1983
T M, Pollock, J, Morris
openaire   +2 more sources

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Lancet, The, 2020
Amir Tukhvatulin, Dmitry Shcheblyakov, Alexander Gintsburg   +2 more
exaly  

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Vaccine, 2021
Kathrin U Jansen, Daniel Scott, William Gruber   +2 more
exaly  

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

Vaccine, 2011
Allison Naleway, Martin Kulldorff, James Baggs   +2 more
exaly  

Current controversies in the USA regarding vaccine safety

Expert Review of Vaccines, 2010
Archana Chatterjee
exaly  

Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine

Vaccine, 2015
Josefina Romaguera, Lone Kjeld Petersen, Suzanne M Garland   +2 more
exaly  

Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety – executive summary

Vaccine, 2017
Harry Seifert, Ulrich Heininger, Priya Bahri   +2 more
exaly